First in Human of Single and Multiple Doses of MOR106

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a randomized, double-blind, placebo-controlled, dose-escalation, phase I study for the assessment of safety, tolerability and pharmacokinetics of single ascending doses of MOR106 in healthy male subjects and multiple ascending doses in subjects with moderate to severe atopic dermatitis.
Epistemonikos ID: 20c678f243855de77f75737fc2d391b8916d963c
First added on: May 12, 2024